How To Implement Key Account Management To Improve Your Business
Pharmaceutical companies understand how tough life can be. They have to answer to many different “bosses,” not all of whom really have anything to do with driving their bottom-line sales. While they are trying to generate and develop meaningful relationships with the most important clients while determining how best to handle key account management, they also have to address the demands and whines of regulators, auditors and other forces.
The pharmaceutical company must understand that key account management tactics are very important, while also requiring a dynamic approach, flexible positions and creativity. The key account sometimes has several different points of communication within the pharmaceutical company and this can lead to a certain amount of confusion if not handled correctly. However, it is also true to say that these individual “points” could view the key account from different perspectives, depending upon the job level and/or driving force.
Most pharma consulting experts advise us that a sales executive on the front line, if he or she is motivated by revenues, could not ultimately have the best interests of the client or the company in focus. This is often not a cut and dried situation but rather very subtle, and can nevertheless have an effect on the overall relationship between the two organisations.
Key accounts provide a level of cash flow-based stability to a pharmaceutical company that is difficult to replicate. However, the designation of “key account” status should not be given lightly. It should never be decided based on scale alone, and many other factors must be taken into consideration. It is possible that a high-volume could result in a low bottom-line return, due to the cost of servicing the needs of the client and razor thin margins.
Typically in most organisations, 20% of the clients represent 80% of the value and this business metric is well-established. As such, once an account is designated as potentially “key,” it should be segmented and categorised to determine the best approach. A number of different layers of key account management could exist within a typical organisation and all tiers of management, especially those who regularly interact with clients, must receive correct training in the techniques required to handle every level and type of account.
Many different ways exist to segment and categorise a client, when it comes to the designation of key account status and these include the company’s growth rate, its percentage allocation of profits, total annual sales and peer-to-peer comparison.
The pharmaceutical consulting firm will be the first to tell the company that no two clients are alike and furthermore that no two key accounts can be treated the same, either. Generally, pharmaceutical consultants know how to deal with various levels of accounts and can be very helpful in imparting this level of knowledge to the company’s various staffing points. A critical “mission” statement should be determined for each and every one of the pharmaceutical company’s clients, detailing the terms of the relationship accurately. There should be no “stock” description, but as each key account is of elevated importance to the company’s existence, all staff members must be trained to recognise the difference between “apples and oranges.”
Alan Gillies is the CEO of L2L Consulting, a cutting-edge pharma consultancy firm which specialises in optimising productivity and performance within international companies by applying tailored organisational strategies.

